Drug Profile
Tissue factor pathway inhibitor
Alternative Names: TFPILatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Anticoagulants; Lipoproteins
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Blood coagulation disorders; Reperfusion injury